Dr Christy Goldsmith
Dr Christy Goldsmith undertook a travel fellowship in aspects of SABR in 2009, learning Linac-based technique at the NKI, Amsterdam, and CyberKnife technique at Stanford University hospital, USA. This experience furthered Dr Goldsmith’s interest in SABR technique and she took up a CyberKnife Fellow post at The Harley Street Clinic, London, studying for an MD(Res) thesis on “Optimising dose delivery and tracking accuracy in SABR”. Dr Goldsmith has presented Abstracts on SABR for Oligometastatic disease at ESTRO, ASTRO and the RSS Scientific meeting.
Improving patient outcomes with Stereotactic Ablative Body Radiotherapy (SABR)
SABR is a fairly new Radiotherapy treatment approach. High dose radiotherapy is delivered with pin-point accuracy. Patients typically benefit from improved tumour control, and fewer side effects. The treatment duration is also shorter than “standard” radiotherapy meaning patients can get back to normal life much quicker. SABR will be explained to the audience.
EVEN MORE SEMINARS
Professor Alex Mirnezami University of Southampton
Biomarkers of Epithelial to Mesenchymal Transition and their clinical relevance in colorectal cancer
Dr Tom Newsom-Davis Leaders in Oncology Care (Part of HCA healthcare UK)
Immunotherapy and innovative systemic treatments in Oncology
Michael Schreiber Brain Tumor Foundation, Chairman
Brain Tumors - Innovation, support and advocacy
Prof Samuel Janes University College London Hospitals
Prof Adam Waldman MRC Institute of Genetics & Molecular Medicine CANCER RESEARCH UK Imaging
Biomarkers in Adult Glioma